Moga, Punjab, successfully organised the 22nd International Cyclodextrin Symposium (ICS-22) from October 23 to 25, 2026, bringing together approximately 2,400 participants representing 26 Indian ...

Japanese med-tech giant Omron unveils blood pressure monitor production plant near Chennai: Peethaambaran Kunnathoor, Chennai Monday, November 2, 2026, 13:15 Hrs [IST] Japanese me ...

Clinics On Cloud secures USD 12.5 million in Series A funding: Our Bureau, Mumbai Monday, November 2, 2026, 17:15 Hrs [IST] Pune-based health-tech startup, Clinics On Cloud has se ...

Valion Bio advancing Entolimod into US government-funded therapeutic efficacy study following positive safety results: San Antonio, Texas Monday, November 2, 2026, 18:00 Hrs [IST] ...

Hikal's Bengaluru API facility earns Swissmedic GMP certification: Our Bureau, Mumbai Monday, November 2, 2026, 17:40 Hrs [IST] Hikal Limited, a trusted life sciences partner to g ...

Nuvation Bio to expand pivotal phase 3 SIGMA study of safusidenib for IDH1-mutant glioma to six European countries: New York Monday, November 2, 2026, 16:00 Hrs [IST] Nuvation Bio ...

EMA validates Immunome’s MAA for varegacestat, an oral, once-daily gamma secretase inhibitor to treat adults with desmoid tumours: Bothell, Washington Monday, November 2, 2026, ...

Bengaluru Tech Summit 2026 to be held from Nov 17-19 at Bangalore International Exhibition Centre: Our Bureau, Bengaluru Monday, November 2, 2026, 09:00 Hrs [IST] ...

Granules India’s Gagillapur facility completes US FDA inspection with eleven observations: Our Bureau, Mumbai Monday, November 2, 2026, 14:45 Hrs [IST] Granules India Limited an ...

The Institute has signed a Memorandum of Understanding with Coloplast India (the India arm of Coloplast in Humlebæk, Denmark), to establish a Centre of Excellence for Ostomy Care, aimed at ...

Pace Life Sciences completes successful EMA GMP inspection at New Jersey facility: Minneapolis, Minnesota Monday, November 2, 2026, 17:00 Hrs [IST] Pace Life Sciences, a division ...

UK MHRA grants marketing approval to Ultragenyx’s triheptanoin to treat adults and children with a group of rare inherited disorders: United Kingdom Monday, November 2, 2026, 11 ...